SCHEMBL1720832

SCHEMBL1720832

O=c1[nH]c(=O)c2[nH]c(CCCc3ccc(Cl)nc3)nc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 1/20 0.37
GSK3B P49841 1/20 0.37
KDM4E B2RXH2 4/20 0.36
GAA P10253 4/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
XDH P47989 2/20 0.36
DAO P14920 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RUNX1 Q01196 1/20 0.34
CBFB Q13951 1/20 0.34
ACHE P22303 1/20 0.33
GDA Q9Y2T3 1/20 0.33
CYP3A4 P08684 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
P2RY12 Q9H244 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23860264 0.74 TPH1 (0.36) ALDH1A1CYP3A4
SCHEMBL6233162 0.71 XDH (0.51) ADORA2BGSK3BMAPTXDHALDH1A1
SCHEMBL7035603 0.71 ADORA2B (0.55) ADORA2BGSK3BKDM4EMAPTXDH
SCHEMBL3399435 0.70 MAPT (0.48) ADORA2BKDM4EMAPTXDHALDH1A1
SCHEMBL4013561 0.70 ADORA2B (0.42) ADORA2BGSK3BKDM4EMAPTALDH1A1
SCHEMBL3118423 0.70 XDH (0.54) ADORA2BMAPTXDHHCAR2
SCHEMBL4320462 0.69 ADORA2B (0.41) ADORA2BDAO
SCHEMBL9430030 0.69 XDH (0.43) ADORA2BMAPTXDHALDH1A1ACHE
SCHEMBL11661802 0.69 XDH (0.56) MAPTXDHHCAR2
SCHEMBL9430825 0.69 XDH (0.43) ADORA2BMAPTXDHALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405917-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS Advinus Therapeutics Private Limited (IN) 2012-01-18 EP disclosed
WO-2010103547-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-09-16 WO disclosed